Caption Management »

Rocket Pharmaceuticals shares owned by Caption Management

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 60k 29.97
2023-09-30 $1.6M 80k 20.49
2022-12-31 $9.5M 483k 19.57
2022-09-30 $4.1M 255k 15.96
2021-06-30 $1.3M 30k 44.29

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Rocket Pharmaceuticals

Wellington Management Company
Vanguard Group
Maverick Capital
Westfield Capital Management Company
T. Rowe Price Associates
Citadel Advisors
Avidity Partners Management
Perceptive Advisors
Frazier Life Sciences Management
Boxer Capital
Logos Global Management
venBio Select Advisor
Cowen And Company
Franklin Resources
Bamco

View all funds holding Rocket Pharmaceuticals